Pharmaceutical Executive January 26, 2026
Mike Hollan

Key Takeaways

  • Biotech data visualization is often static and fragmented, limiting the ability to see integrated patient journeys and scientific signals.
  • Effective visualization enhances decision-making, cross-functional alignment, and communication with stakeholders, leading to better patient and business outcomes.
  • Biotech should embed visualization throughout the data lifecycle, adopt interactive experiences, and leverage AI-assisted analytics.
  • Overcoming barriers like fragmented data, limited resources, and cultural challenges requires multi-departmental cooperation and treating visualization as a strategic capability.

Poor visualization techniques can oversimplify reality and make data less potent.

Sunitha Venkat, vice president of data services and insights at Conexus Solutions, spoke with Pharmaceutical Executive about the importance of using high quality data visualization methods. According to her, the industry has been relying...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Interview / Q&A, Pharma / Biotech, Trends
Biotech investor Cormorant secures $150M for another SPAC deal
The Future of Pharmacovigilance Technology: How AI and Automation Are Redefining Drug Safety
Introducing the Sunday Times Tech 100: Life sciences part 1
China’s edge in early-stage drugmaking ‘likely to persist,’ Pitchbook says
Promising New Weight-Loss Pill From South Korea’s Sam Chun Dang Pharm Mints Country’s Newest Billionaire

Share Article